发明名称 ECT2 ONCOGENE AS A THERAPEUTIC TARGET AND PROGNOSTIC INDICATOR FOR LUNG AND ESOPHAGEAL CANCER
摘要 The invention features methods for detecting lung cancer or esophageal cancer, by detecting over-expression of ECT2 compared the normal organs. Also disclosed are methods of identifying compounds for treating and preventing lung cancer or esophageal cancer, based on the over-expression of ECT2 in the lung cancer or esophageal cancer, the cell proliferation function of ECT2. Also, provided are a method for treating lung cancer or esophageal cancer by administering a double-stranded molecule against the ECT2 gene or an antibody against ECT2 protein. The invention also provides products, including the double-stranded molecules and vectors encoding them, as well as compositions comprising the molecules or vectors, useful in the provided methods.
申请公布号 US2011319280(A1) 申请公布日期 2011.12.29
申请号 US200913002977 申请日期 2009.07.16
申请人 NAKAMURA YUSUKE;DAIGO YATARO;TOGASHI AKIRA;ONCOTHERAPY SCIENCE, INC. 发明人 NAKAMURA YUSUKE;DAIGO YATARO;TOGASHI AKIRA
分类号 C40B30/04;C12Q1/68;G01N33/53;G01N33/566 主分类号 C40B30/04
代理机构 代理人
主权项
地址